EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Key Targets of Herbal Compounds for Liver Fibrosis Using Network Pharmacology Combined With Transcriptomics

Chen Chen iD, Bo Huang, Mengting Hu, Shengpeng Yang, Bo Lan, Dejun Cui iD

Gastroenterology Research and Practice · 2026-01 · 2026 (1)

DOI: 10.1155/grp/9985154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastroenterology Research and Practice, online erschienen am 14.04.2026. Verfasst von Chen Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China, 5055.cn. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chinese herbal compound prescriptions have demonstrated efficacy in preventing and treating liver fibrosis (LF), though their mechanisms remained unclear. This study is aimed at identifying diagnostic biomarkers and elucidating the molecular mechanism underlying the effects of the TCM prescription on LF. LF‐related datasets (GSE162694, GSE84044, and GSE136103) were obtained from a public database. Active ingredient–related target genes (AIRTGs) and LF‐related target genes (LFRTGs) were intersected with differentially expressed genes (DEGs) between the LF and normal control (NC) group to select candidate genes. Subsequently, biomarkers for LF diagnosis were determined using Boruta and LASSO algorithms, receiver operating characteristic (ROC), and expression analyses. A nomogram was constructed to evaluate the capability of these biomarkers for predicting LF risk. Furthermore, GSEA and immunoinfiltration analysis were conducted, along with single‐cell analysis to identify relevant cell types in LF. COL3A1 and ALOX5 were identified as diagnostic biomarkers for LF, and the nomogram was proven effective in predicting LF risk. GSEA showed that COL3A1 might play vital roles in cell growth and differentiation, extracellular matrix organization, and cell–matrix interactions. The functions of ALOX5 might be associated with cell–cell interaction, cytoskeletal regulation, and so forth. Immunoinfiltration analysis revealed that activated dendritic cells (DCs) were highly infiltrated, whereas monocytes were less infiltrated in LF. COL3A1 expression was positively correlated with monocytes, but both COL3A1 and ALOX5 showed negative correlations with activated DCs. Single‐cell analysis identified nine cell types, with macrophages, B cells, and mesenchyme cells emerging as key cell types. Cell communication analysis demonstrated stronger interactions between macrophages and mesenchymal cells in the LF group. Pseudotime analysis unveiled that the expression of ALOX5 was upregulated and then downregulated, whereas that of COL3A1 was gradually downregulated during the midstage and stabilized thereafter. COL3A1 and ALOX5 may serve as biomarkers for the diagnosis and treatment of LF with Chinese herbal compound prescriptions, contributing to more accurate diagnosis and improved LF therapy.

Schlagwörter

Stichwörter der Autor:innen

Chinese herbal compound prescriptionbiomarkersliver fibrosisnomogramsingle-cell RNA sequencing

Autor:innen und Institutionen

  • Department of Gastroenterology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China, 5055.cn.
  • Guizhou Medical University, Guiyang, China, gmc.edu.cn.
  • Department of Hepatobiliary Surgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China, 5055.cn.
  • Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China, 5055.cn.

ORCID-Profile: Chen Chen, Dejun Cui

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, C., Huang, B., Hu, M., Yang, S., Lan, B., & Cui, D. (2026). Identification of Key Targets of Herbal Compounds for Liver Fibrosis Using Network Pharmacology Combined With Transcriptomics. Gastroenterology Research and Practice, 2026(1). https://doi.org/10.1155/grp/9985154

Vancouver

Chen C, Huang B, Hu M, Yang S, Lan B, Cui D. Identification of Key Targets of Herbal Compounds for Liver Fibrosis Using Network Pharmacology Combined With Transcriptomics. Gastroenterology Research and Practice. 2026;2026(1). doi:10.1155/grp/9985154

BibTeX
@article{Chen2026,
  author = {Chen, Chen and Huang, Bo and Hu, Mengting and Yang, Shengpeng and Lan, Bo and Cui, Dejun},
  title = {Identification of Key Targets of Herbal Compounds for Liver Fibrosis Using Network Pharmacology Combined With Transcriptomics},
  journal = {Gastroenterology Research and Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/grp/9985154}
}
Kostenlos starten →